PQ 595
595. Deputy Ken O'Flynn asked the Minister for Health the governance and conflict-of-interest policies that apply to officials, clinicians, external advisors and members of the HSE’s Programme for Gender Healthcare when developing or advising on gender healthcare policy, including disclosure requirements relating to links with pharmaceutical companies, advocacy organisations or service providers; and the way these safeguards are monitored and enforced. [64753/25]
Introduced
20 November 2025
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
20 November 2025
Summary
595. Deputy Ken O'Flynn asked the Minister for Health the governance and conflict-of-interest policies that apply to officials, clinicians, external advisors and members of the HSE’s Programme for Gender Healthcare when developing or advising on gender healthcare policy, including disclosure requirements relating to links with pharmaceutical companies, advocacy organisations or service providers; and the way these safeguards are monitored and enforced. [64753/25]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Health Services
Health Services
xml · EN · 20 November 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2025-11-20/595/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2025-11-20/pq_595